some description

results_A5023527846.json

{"Adrien Nougarède":{"adrien-nougarede-1":{"works":["https://openalex.org/W2035075323","https://openalex.org/W2590552425","https://openalex.org/W2783142785","https://openalex.org/W2886260233","https://openalex.org/W2897249717","https://openalex.org/W3006173183","https://openalex.org/W3169142157","https://openalex.org/W3172197942","https://openalex.org/W3185390703","https://openalex.org/W3194982446","https://openalex.org/W4220927123","https://openalex.org/W4224240037","https://openalex.org/W4318245017","https://openalex.org/W4361234916","https://openalex.org/W4361234936","https://openalex.org/W4361235002","https://openalex.org/W4361235035","https://openalex.org/W4361235045","https://openalex.org/W4361235067","https://openalex.org/W4361235080","https://openalex.org/W4361235107","https://openalex.org/W4361235131","https://openalex.org/W4361235154","https://openalex.org/W4361235155","https://openalex.org/W4361235169","https://openalex.org/W4361235183","https://openalex.org/W4361235203","https://openalex.org/W4361235222","https://openalex.org/W4361235278","https://openalex.org/W4361235352","https://openalex.org/W4361235363","https://openalex.org/W4361235529","https://openalex.org/W4361235625","https://openalex.org/W4382651703"],"institutions":["Centre Léon Bérard"," Cancer Research Center of Lyon"," Claude Bernard University Lyon 1"," Inserm"," French National Centre for Scientific Research","Cancer Research Center of Lyon","Cancer Research Center of Lyon"," Centre Léon Bérard"," Claude Bernard University Lyon 1"," Inserm"," French National Centre for Scientific Research"," Hôpital Lyon Sud","Sunnybrook Health Science Centre"," University of Toronto","Cancer Research Center of Lyon"," Centre Léon Bérard"," Claude Bernard University Lyon 1"," Inserm"," French National Centre for Scientific Research"," Hôpital Lyon Sud"," Hospices Civils de Lyon","Université Grenoble Alpes"," Inserm"," French National Centre for Scientific Research","French National Centre for Scientific Research"," Université Grenoble Alpes"," Inserm","Sunnybrook Health Science Centre"," University of Toronto","Hôpital Lyon Sud"],"subject":"Bcl-2 Homolog Nrz, IP3 receptor, Calcium Signaling, Zebrafish epiboly, molecular biology, Center Léon Bérard, Lyon institutions, Science Signaling (2014), Benjamin Bonneau, Ruth Rimokh, Nikolay Popgeorgiev, Julien Prudent, Nadine Peyriéras, Germain Gillet","titles":"The Bcl-2 Homolog Nrz Inhibits Binding of IP 3 to Its Receptor to Control Calcium Signaling During Zebrafish Epiboly; Molecular basis of BCL2L10/Nrh oncogenic activity in breast cancer; Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Improved IRE1 and PERK Pathway Sensors for Multiplex Endoplasmic Reticulum Stress Assay Reveal Stress Response to Nuclear Dyes Used for Image Segmentation; BH4-mimetics and -antagonists: an emerging class of Bcl-2 protein modulators for cancer therapy; The apoptosis inhibitor Bcl-xL controls breast cancer cell migration through mitochondria-dependent reactive oxygen species production; P034 Human primary 2D culture as a tool to explore JAK1 pathway inhibition in the intestinal epithelium using siRNA technology; Tuning the immunostimulation properties of cationic lipid nanocarriers for nucleic acid delivery; Therapeutic siRNAs Targeting the JAK/STAT Signalling Pathway in Inflammatory Bowel Diseases; Tuning the Immunostimulation Properties of Cationic Lipid Nanocarriers for Nucleic Acid Delivery; Leaky gut model of the human intestinal mucosa for testing siRNA-based nanomedicine targeting JAK1; Efficacy and specificity of inhibitors of BCL-2 family protein interactions assessed by affinity measurements in live cells; Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and chemotherapy outcome; Figure S7 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Supplementary Material & Methods, tables, movie legend from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figures S2 & S3 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Supplementary Movie S1 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S6 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S1 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S4 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Supplementary Material & Methods, tables, movie legend from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Data from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figures S2 & S3 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figures S8 & S9 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S7 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S1 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S6 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Supplementary Movie S1 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Data from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S5 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S5 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figure S4 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Figures S8 & S9 from Breast Cancer Targeting through Inhibition of the Endoplasmic Reticulum-Based Apoptosis Regulator Nrh/BCL2L10; Nrh L11R single nucleotide polymorphism, a new prediction biomarker in breast cancer, impacts endoplasmic reticulum-dependent Ca2+ traffic and response to neoadjuvant chemotherapy"},"adrien-nougarede-2":{"works":["https://openalex.org/W2589246507"],"institutions":[],"subject":"Plant Biology, Rhizogenesis, Plant Physiology","titles":"NATURAL AND EXPERIMENTAL EXPRESSION OF RHIZOGENESIS : BEHAVIOUR OF TARGET AND NON TARGET CELLS"}}}